2,542
Views
28
CrossRef citations to date
0
Altmetric
Clinical Study

The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial

, , , , , , , , & show all
Pages 242-248 | Received 25 Aug 2015, Accepted 20 Nov 2015, Published online: 04 Jan 2016

References

  • Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–2414.
  • Lin M, Du L, Brandtzaeg P, Pan-Hammarstrom Q. IgA subclass switch recombination in human mucosal and systemic immune compartments. Mucosal Immunol. 2014;7(3):511–520.
  • Appel GB, Waldman M. The IgA nephropathy treatment dilemma. Kidney Int. 2006;69(11):1939–1944.
  • Roberts IS. Pathology of IgA nephropathy. Nat Rev Nephrol. 2014;10(8):445–454.
  • Xie Y, Chen X, Nishi S, Narita I, Gejyo F. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int. 2004;65(4):1135–1144.
  • Masieri S, Trabattoni D, Incorvaia C, et al. A role for Waldeyer’s ring in immunological response to allergens. Curr Med Res Opin. 2014;30(2):203–205.
  • Yamamoto Y, Hiki Y, Nakai S, et al. Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy. Clin Exp Nephrol. 2013;17(2):218–224.
  • Ohya M, Otani H, Minami Y, et al. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. Clin Nephrol. 2013;80(1):47–52.
  • Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15(1):157–163.
  • Kawamura T, Yoshimura M, Miyazaki Y, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant. 2014;29(8):1546–1553.
  • Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944.
  • Sato M, Hotta O, Tomioka S, et al. Cohort study of advanced IgA nephropathy: Efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract. 2003;93(4):c137–c145.
  • Liu Y, Liu H, Tu X, et al. Study of tonsillectomy for IgA nephropathy patients: Short- and longer-term observation. Int Urol Nephrol. 2014;46(6):1153–1159.
  • Chen YZ, Gao Q, Zhao XZ, et al. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy. Intern Med. 2010;49(19):2049–2055.
  • Peters CD, Ring T. Validation of the Oxford classification of IgA nephropathy: Valid or invalid? Kidney Int. 2015;87(3):661–662.
  • Zhang J, Wang C, Tang Y, et al. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy. Nephrology (Carlton). 2013;18(2):125–131.
  • Moriyama T, Tanaka K, Iwasaki C, et al. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9(3):e91756.
  • Liu LL, Wang LN, Jiang Y, et al. Tonsillectomy for IgA nephropathy: A meta-analysis. Am J Kidney Dis. 2015;65(1):80–87.
  • Mestecky J, Raska M, Julian BA, et al. IgA nephropathy: Molecular mechanisms of the disease. Annu Rev Pathol. 2013;8:217–240.
  • Novak J, Julian BA, Tomana M, Mestecky J. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol. 2008;28(1):78–87.
  • Gharavi AG, Kiryluk K, Choi M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43(4):321–327.
  • Zand L, Fervenza FC. Does tonsillectomy have a role in the treatment of patients with immunoglobulin A nephropathy? Nephrol Dial Transplant. 2014;29(8):1456–1459.
  • Nakata J, Suzuki Y, Suzuki H, et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One. 2014;9(2):e89707.
  • Nagayama Y, Nishiwaki H, Hasegawa T, et al. Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy. Clin Exp Nephrol. 2015;19(4):646–652.
  • Kovacs T, Vas T, Kovesdy CP, et al. Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients. Int Urol Nephrol. 2014;46(11):2175–2182.
  • Huang H, Sun W, Liang Y, et al. CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: A clinical and pathological study. Int Urol Nephrol. 2014;46(12):2361–2369.
  • Wu G, Peng YM, Liu FY, Xu D, Liu C. The role of memory B cell in tonsil and peripheral blood in the clinical progression of IgA nephropathy. Hum Immunol. 2013;74(6):708–712.
  • Suzuki Y, Tomino Y. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: Insights from animal models. Semin Nephrol. 2008;28(1):66–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.